Possible Bearish Signals With Chemed Insiders Disposing Stock
Possible Bearish Signals With Chemed Insiders Disposing Stock
Over the past year, many Chemed Corporation (NYSE:CHE) insiders sold a significant stake in the company which may have piqued investors' interest. When evaluating insider transactions, knowing whether insiders are buying is usually more beneficial than knowing whether they are selling, as the latter can be open to many interpretations. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period.
在過去的一年裏,許多Chemed Corporation(紐交所:CHE)的內部人士出售了公司的一部分股份,這可能引起了投資者的關注。評估內部交易時,了解內部人士是否在買入通常比了解他們是否在賣出更有利,因爲後者可能有多種解讀。然而,如果有多個內部人士在特定時間段內出售股票,股東們應該深入調查一下。
While insider transactions are not the most important thing when it comes to long-term investing, we would consider it foolish to ignore insider transactions altogether.
雖然在長期投資方面內部交易並非最重要的事情,但完全忽略內部交易是愚蠢的。
Chemed Insider Transactions Over The Last Year
過去一年Chemed內部人士交易情況
Over the last year, we can see that the biggest insider sale was by the VP & Director, Thomas Hutton, for US$2.8m worth of shares, at about US$576 per share. So what is clear is that an insider saw fit to sell at around the current price of US$525. While we don't usually like to see insider selling, it's more concerning if the sales take place at a lower price. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive).
在過去的一年裏,我們看到最大的一筆內部銷售是由副總裁兼董事Thomas Hutton以價值280萬美元的股份出售的,約爲每股576美元。因此很明顯,有位內部人士選擇在當前價格約爲525美元時出售。雖然我們通常不喜歡看到內部人士出售股票,但如果在更低的價格下銷售,那就更令人擔憂。在這種情況下,大手交易發生在當前價格附近,所以情況並不太糟(但這仍然不是個好現象)。
Insiders in Chemed didn't buy any shares in the last year. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
在過去一年裏,Chemed的內部人士沒有購買任何股份。您可以在下面的圖表中看到過去一年內部人士交易(公司及個人)的情況。如果您想準確知道是誰出售了股票,出售了多少,以及何時出售,只需點擊下面的圖形!
I will like Chemed better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.
如果我看到一些大額內部買入,我會更喜歡Chemed。在我們等待的同時,查看這份免費列表,裏面有一些被低估的小盤股票,最近有相當大的內部買入。
Chemed Insiders Are Selling The Stock
Chemed內部人士正在出售該股票
Over the last three months, we've seen significant insider selling at Chemed. In total, insiders dumped US$3.6m worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.
在過去三個月中,我們看到Chemed出現了顯著的內部出售。總的來說,內部人士在此期間拋售了價值360萬美元的股票,而我們沒有記錄到任何購買。在這種情況下,很難爭辯說所有內部人士都認爲這些股票便宜。
Insider Ownership Of Chemed
Chemed的內部持股
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It's great to see that Chemed insiders own 1.6% of the company, worth about US$132m. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.
查看公司內部人士的總股份持有情況可以幫助您了解他們是否與普通股東的利益一致。通常,內部人士的持股比例越高,內部人士越可能被激勵長期發展公司。很高興看到Chemed的內部人士擁有公司1.6%的股份,價值約13200萬美元。我喜歡看到這樣的內部持股比例,因爲這增加了管理層考慮股東最佳利益的機會。
So What Do The Chemed Insider Transactions Indicate?
那麼,Chemed的內部交易表明了什麼?
Insiders sold stock recently, but they haven't been buying. And there weren't any purchases to give us comfort, over the last year. On the plus side, Chemed makes money, and is growing profits. It is good to see high insider ownership, but the insider selling leaves us cautious. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Chemed. For example - Chemed has 1 warning sign we think you should be aware of.
內部人士最近賣出了股票,但他們沒有買入。在過去一年中沒有任何購買來讓我們感到安心。值得慶幸的是,Chemed賺錢,並且利潤在增長。看到高比例的內部持股是好事,但內部人士的賣出讓我們感到謹慎。除了了解內部交易情況外,識別Chemed所面臨的風險也是有益的。例如——Chemed有一個我們認爲您應該關注的警告跡象。
But note: Chemed may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
但請注意:Chemed可能不是最值得購買的股票。因此,請查看這份高ROE和低債務的有趣公司名單。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
在本文中,內部人士是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall St的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均沒有持倉。
譯文內容由第三人軟體翻譯。